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Cryptosporidium parvum is one of several Cryptosporidium spp. that cause the
parasitic infection cryptosporidiosis. Cryptosporidiosis is a diarrheal infection
that is spread via the fecal–oral route and is commonly caused by contaminated
drinking water. Triosephosphate isomerase is an enzyme that is ubiquitous to all
organisms that perform glycolysis. Triosephosphate isomerase catalyzes the
formation of glyceraldehyde 3-phosphate from dihydroxyacetone phosphate,
which is a critical step to ensure the maximum ATP production per glucose
molecule. In this paper, the 1.55 A ˚ resolution crystal structure of the open-loop
form of triosephosphate isomerase from C. parvum Iowa II is presented. An
unidentiﬁed electron density was found in the active site.
1. Introduction
Triosephosphate isomerase (TIM) is an enzyme that is only active in
its dimeric form and that has been found in almost all organisms
that participate in glycolysis. The aldolase (fourth) step of glycolysis
ends with two products: dihydroxyacetone phosphate (DHAP) and
d-glyceraldehyde 3-phosphate (GAP). Only GAP is able to proceed
to the next phase of glycolysis. During the ﬁfth glycolysis step, TIM
catalyzes the reversible isomerization of dihydroxyacetone phos-
phate (DHAP) to d-glyceraldehyde 3-phosphate (GAP) (see Fig. 1).
TIM is essential for maximum energy production. Because of its
important role in glycolysis, triosephosphate isomerase has been
described as an ‘an attractive target for drug design against parasites’
(Mande et al., 1994).
As of January 2011, 118 structures of TIM have been released in
the PDB. The ﬁrst apo structure of TIM from chicken muscle was
deposited in 1976 (PDB entry 1tim; Banner et al., 1976). This was
followed in 1990 by the deposition of the ﬁrst ligand-bound structure
of yeast TIM in the PDB [PDB entries 1ypi (Lolis et al., 1990) and
2ypi (Lolis & Petsko, 1990)]. Since then, many other TIM structures
from 31 organisms, with and without ligands, have been deposited.
TIM structures have been observed in both a closed and an open
form. The open form has been observed for apo TIM, while ligand
binding induces the closure of a loop. However, one ligand-bound
structure of TIM from Plasmodium falciparum has been described
with both an open and a closed conformation of the loop (Partha-
sarathy et al., 2003).
Cryptosporidium parvum is a protozoan parasite that causes
cryptosporidiosis. Unlike the closely related C. hominis, which
Figure 1
Reaction catalyzed by TIM.colonizes humans almost exclusively, C. parvum can infect a variety
of vertebrates via transmission of oocytes. Together, Cryptosporidium
spp. are a leading cause of morbidity and mortality in mammals,
resulting primarily in gastrointestinal problems and diarrhea, or
death in the immunocompromised. Currently, there are no reliable
treatments for cryptosporidiosis. Paromomycin, azithromycin and
nitazoxanide have all shown partial efﬁcacy in reducing disease
severity in individuals by shortening diarrheal duration (Gargala,
2008; Mead, 2002). However, for immunocompromised patients it
is necessary to restore an effective immune response in addition
to antimicrobial treatment of the Cryptosporidium infection itself
(Gargala, 2008). Here, we present the 1.55 A ˚ crystal structure of the
apo form of TIM from C. parvum Iowa II as part of a structure-based
drug-discovery effort.
2. Methods
2.1. Protein expression and purification
The gene encoding the full-length (Met1–Gln250) triosephosphate
isomerase (UniProt Q5CSE7; residues 1–250) was PCR-ampliﬁed in
a 96-well format using genomic DNA as the template. The primers
were designed with an additional ligase-independent cloning (LIC;
Aslanidis & de Jong, 1990) sequence at their 50 ends that is compli-
mentary to the LIC sequence in the plasmid vector. Puriﬁed PCR
products were then cloned via LIC into the AVA0421 expression
vector (Quartley et al., 2009), which provides a C3-cleavable hexa-
histidine tag at the N-terminus of the expressed protein with the
sequence MAHHHHHHMGTLEAQTQ0GPGS. The recombinant
plasmids were then transformed into Escherichia coli Rosetta Oxford
strain [BL21*(DE3)-R3-pRARE2] cells for expression testing.
Soluble protein was observed and the target was moved on to large-
scale expression. The protein was given the internal designation
CrpaA.01119.a.A1 and will be referred to as CrpaA.01119.a.A1/TIM.
Starter cultures of LB broth with appropriate antibiotics were
grown for  18 h at 310 K. ZYP-5052 auto-induction medium was
freshly prepared as per UW-PPG protocols (Studier, 2005; Choi et al.,
2011). Antibiotics were added to 2 l bottles of sterile auto-induction
medium. The bottles were inoculated with the entire overnight
culture. Inoculated bottles were then placed into a LEX Bioreactor
(Harbinger Biotechnology, Toronto, Ontario). Cultures were grown
for  24 h at 298 K. The temperature was reduced to 288 K and the
culture was grown for a further  60 h. To harvest, the medium was
centrifuged at 4000g for 20 min at 277 K. The cell paste was ﬂash-
frozen in liquid nitrogen and stored at 193 K.
The frozen pellet was thawed and completely resuspended in lysis
buffer (20 mM HEPES pH 7.2–7.4, 300 mM NaCl, 5% glycerol,
30 mM imidazole, 0.5% CHAPS, 10 mM MgCl2,3m M  -mercapto-
ethanol, 1.3 mg ml
 1 protease-inhibitor cocktail and 0.05 mg ml
 1
lysozyme). The resuspended cell pellet was then disrupted on ice for
15 min with a Branson Digital Soniﬁer 450D (set to 70% amplitude,
with alternating cycles of 5 s pulse-on and 10 s pulse-off). The cell
debris was incubated with 20 units ml
 1 Benzonase nuclease (EMD,
San Diego, California, USA) at room temperature for at least 40 min
and clariﬁed by centrifugation in a Sorvall RC5 (Thermo Scientiﬁc,
Pittsburgh, Pennsylvania, USA) at 10 000 rev min
 1 for 60 min at
277 K. The tagged TIM from C. parvum was separated from the
clariﬁed cell lysate by immobilized metal-afﬁnity chromatography
(IMAC) on a HisTrap FF 5 ml column (GE Biosciences, Piscataway,
New Jersey, USA) equilibrated with binding buffer (20 mM HEPES
pH 7.0, 300 mM NaCl, 5% glycerol, 30 mM imidazole, 1 mM
tris(2-carboxyethyl)phosphine (TCEP). The recombinant protein was
eluted in 500 mM imidazole plus 1 mM TCEP. Cleavage of the
N-terminal His tag was accomplished by overnight incubation with
His-MBP-3C protease at 277 K while dialyzing in 25 mM HEPES pH
7.0, 300 mM NaCl, 5% glycerol, 1 mM TCEP, 0.025% sodium azide.
The cleaved protein was recovered both in the ﬂowthrough and in the
wash fractions, utilizing the same buffers as for the initial IMAC step.
After afﬁnity-tag cleavage, a tag remnant GPGS was left at the N-
terminus of the full-length protein. The protein was further resolved
by size-exclusion gel chromatography (SEC; Superdex 75 26/60; GE
Biosciences, Piscataway, New Jersey, USA). Pure fractions collected
in SEC buffer (20 mMHEPES pH 7.0, 300 mMNaCl, 2 mMDTT, 5%
glycerol) as a single peak were analyzed using SDS–PAGE and
SimplyBlue Safestain (Invitrogen, Carlsbad, California, USA). The
protein was then pooled, concentrated to 75.3 mg ml
 1, ﬂash-frozen
and stored at 193 K in SEC buffer. Further details can be found in
Bryan et al. (2011).
2.2. Crystallization
Thawed protein was used to set up four sparse-matrix screens
(JCSG+, Cryo and Wizard from Emerald BioStructures, Bainbridge
Island, Washington, USA and PACT from Molecular Dimensions,
Apopka, Florida, USA) following an extended Newman strategy
(Newman et al., 2005). 0.4 ml protein solution was mixed with 0.4 ml
well solution and equilibrated against a 100 ml reservoir using 96-well
Compact Jr crystallization plates (Emerald BioStructures). Crystals
suitable for diffraction studies were found in condition G8 from
the PACT screen: 100 mM Bis-Tris propane pH 7.5, 200 mM sodium
sulfate, 20% PEG 3350. The crystals were cryoprotected with an
additional 25% ethylene glycol.
2.3. Data collection and structure determination
An X-ray diffraction data set was collected on 25 October 2009 on
ALS beamline 5.0.3 at the Berkeley Center for Structural Biology,
which is equipped with a 3   3 tiled ADSC Q315r detector. 180
images were collected at a wavelength of 0.9774 A ˚ with a crystal-
to-detector distance of 225 mm, a ’-slicing of 1  per image and an
exposure time of 1 s. The diffraction data were processed with XDS/
XSCALE (Kabsch, 2010; see Tables 1 and 2). The crystals belonged
to space group P21; the diffraction limit was 1.55 A ˚ .
Calculation of the packing density (Matthews, 1968) suggested two
molecules of CrpaA.01119.a.A1/TIM per asymmetric unit, with a VM
of 2.56 A ˚ 3 Da
 1 and 52% solvent content. A search of the PDB for
sequence homology yielded a TIM from P. falciparum (PDB entry
2vfd; Gayathri et al., 2009) as the closest homolog,with 47% sequence
identity. The search model was derived from monomer A of PDB
entry 2vfd with the CCP4 program CHAINSAW (Stein, 2008; Winn
structural communications
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Table 1
Data-collection statistics.
Values in parentheses are for the highest of 20 resolution shells.
Beamline ALS 5.0.3
Wavelength (A ˚ ) 0.9765
Space group P21
Unit-cell parameters (A ˚ ,  ) a = 53.56, b = 71.93, c = 75.38,   = 106.4
Resolution range (A ˚ ) 20–1.55 (1.59–1.55)
Mean I/ (I) 12.9 (2.9)
Rmerge† 0.077 (0.364)
Completeness (%) 99.0 (91.3)
Multiplicity 3.6 (2.5)
No. of unique reﬂections 79305 (5364)
Wilson B factor (A ˚ 2) 10.4
† Rmerge =
P
h
P
i jIiðhÞ h IðhÞij=
P
h
P
i IiðhÞ.et al., 2011) by trimming nonconserved amino acids to the C
  atom
while maintaining conserved residues (Schwarzenbacher et al., 2004).
Molecular replacement was performed with the CCP4 program
Phaser (McCoy et al., 2007) using data between 20 and 3.5 A ˚
resolution. The two molecules could be placed with high scores:
RFZ1 = 13.4, TFZ1 = 11.8, LLG1 = 207, RFZ2 = 11.3, TFZ2 = 23.6,
LLG = 797. The model was then extended by ARP/wARP (Langer et
al., 2008), which built 471 residues in six chains with Rwork = 0.208 and
Rfree = 0.273. The model was then iteratively extended manually using
Coot (Emsley et al., 2010) followed by cycles of reciprocal-space
reﬁnement with the CCP4 program REFMAC5 (Murshudov et al.,
2011). The ﬁnal model could be reﬁned with one TLS group per chain
to an Rwork of 0.157 and an Rfree of 0.188 with good stereochemistry
(see Fig. 2). The model was validated with the validation tools in Coot
and MolProbity (Chen et al., 2010). The ﬁnal model extended from
Ser2 to Gln250 in both chains. For each chain, a sodium ion was
modelled binding to the carbonyl C atoms of Cys225 and Leu228 and
to the hydroxyl group of Tyr5. In both  A-weighted Fo   Fc maps
contoured at 3  and  A-weighted 2Fo   Fc maps contoured at 1 
a blob of extra density could be observed in both chains in the
proximity of Gly234. As neither of the components of the crystal-
lization drop could serve as a good interpretation, this density was
modelled as unidentiﬁed (UNK; see x3).
3. Results and discussion
SSGCID target CrpaA.01119.a.A1/TIM crystallized in standard
sparse-matrix screens. A high-resolution data set was collected from
the original screens without further optimization.
CrpaA.01119.a.A1/TIM crystallized with two monomers in the
asymmetric unit. Interface analysis using PISA (Krissinel & Henrick,
2007) conﬁrmed that this was the native dimer. The dimer buries a
surface of 1600 A ˚ 2 per monomer compared with a surface area of
 11 000 A ˚ 2 per monomer; the free binding energy G
int was esti-
mated as  96 kJ mol
 1. Dimers are the active quaternary structure of
TIMs.
The fold of CrpaA.01119.a.A1/TIM is the typical TIM-barrel fold
consisting of a barrel of eight  -strands surrounded by helices (see
Fig. 2). The two monomers are very similar: 249 C
  atoms can be
superimposed with an r.m.s.d. of 0.2 A ˚ .A nSSM (Krissinel &
Henrick, 2004) search of the PDB reveals several other TIMs with
r.m.s.d.s of around 1 A ˚ .
Early studies on TIM revealed that the protein can exist in an open
form and a closed form (Wierenga et al., 1991). The closure of a loop,
commonly called ‘loop 6’ or the ‘active-site loop’, is typically
observed in ligand-bound structures. The closed loop is thought to
protect the reaction intermediates from the environment. The open
conformation is typically found in apo structures. However, in
P. falciparum TIM both open and closed conformations can be
observed in a high-resolution (1.1 A ˚ ) ligand-bound structure (Partha-
sarathy et al., 2003).
In CrpaA.01119.a.A1/TIM the active-site loop extends from resi-
dues Pro168 to Ala178 and isin theopen conformation (Fig. 2). While
the ‘open’ conformation is typical of apo structures, a blob of extra
electron density is observed in proximity to the active site of the
CrpaA.01119.a.A1/TIM structure (see Figs. 2 and 3). This blob of
density almost superimposes with the phosphate group of 2-phospho-
glycerate (2PG) in the TIM structure from Trypanosoma brucei
(PDB entry 4tim; Noble et al., 1991; see Fig. 3a). The two structures
superimpose with an r.m.s.d. of 1.1 A ˚ over 239 residues. Figs. 3(b) and
3(d) compare the 2PG-binding environment in T. brucei TIM with
the extra blob of density in the CrpaA.01119.a.A1/TIM structure.
In the T. brucei TIM structure 2PG is bound to the protein with a
tight hydrogen-bond network. These interactions involve Asn11 N
 2,
His95 N
"2, Glu167 O
"1, Leu232 N (not shown in Fig. 3b), Gly234 N
and Gly235 N, which are structurally conserved between the two
structures. However, the extra density does not entirely match the
phosphate group. Further interactions between 2PG and T. brucei
TIM involve residues from the active-site loop: Gly173 N and
Ser213 N. As the active-site loop in the CrpaA.01119.a.A1/TIM is in
the open conformation, the latter two residues are not structurally
conserved between the two structures.
In the structure of P. falciparum TIM (PDB entry 1o5x; Partha-
sarathy et al., 2003) the active-site loop of subunit B is mostly in an
open conformation, even though ligands are observed in the active
site. In this structure, 2PG has been broken down to into two frag-
ments, which were tentatively identiﬁed as 2-oxoglycerate and
metaphosphate (see Fig. 3c). The 2-oxoglyerate group makes similar
interactions with the protein as described for the T. brucei structure
above. The metaphosphate occupies a similar location as the un-
structural communications
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Figure 2
CrpaA.01119.a.A1/TIM dimer. View of the dimer of CrpaA.01119.a.A1/TIM,
which has the typical TIM-barrel fold. The active-site loop (Pro168–Ala178) is
highlighted in red and is in the typical ‘open’ conformation. Despite the open
conformation of the loop, extra Fo   Fc electron density can be observed in
proximity to the active site. The structure was deposited with UNK atoms as
indicators for unidentiﬁed atoms (highlighted with red spheres).
Table 2
Reﬁnement and model statistics.
Values in parentheses are for the highest of 20 resolution shells.
Beamline ALS 5.0.3
Resolution range (A ˚ ) 20–1.55 (1.59–1.55)
Rcryst† 0.157
Rfree† 0.188
R.m.s.d. bonds (A ˚ ) 0.014
R.m.s.d. angles ( ) 1.42
Protein atoms 3913
Nonprotein atoms 859
Mean B factor (A ˚ 2)9 . 9
Residues in favored region 456 [97%]
Residues in allowed region 6 [1.3%]
Residues in disallowed region 6 [1.3%]
MolProbity‡ score (percentile) 1.46 [90th]
PDB code 3krs
† Rcryst =
P
hkl
   jFobsj j Fcalcj
   =
P
hkl jFobsj. The free R factor was calculated using an
equivalent equation with the 5% of the reﬂections that were omitted from the
reﬁnement. ‡ Chen et al. (2010).identiﬁed density in the CrpaA.01119.a.A1/TIM structure; however,
it does not ﬁll it entirely.
Fig. 3(d) shows a close-up of the active-site region of
CrpaA.01119.a.A1/TIM and the unidentiﬁed electron density. Owing
to similarity to the T. brucei and P. falciparum enzymes, a phosphate
group appears to be a likely explanation for the right part of the extra
electron density. With an additional water molecule on the left, the
density could be fully explained. While the crystallization drop did
structural communications
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Figure 3
Extra density in the active site of CrpaA.01119.a.A1/TIM. (a) A close-up of the active-site loop (red) of CrpaA.01119.a.A1/TIM and the extra blob of density shown in the
same colours as in Fig. 2. The structure of TIM from T. brucei in complex with 2-phosphoglycerate (2PG) is superimposed (PDB entry 4tim) and shown in light-grey ribbons,
with the cofactors shown as colored sticks. The active-site loop of CrpaA.01119.a.A1/TIM is in the open conformation, while the active-site loop of ligand-bound TIM from
T. brucei is closed. The extra density in the CrpaA.01119.a.A1/TIM structure, shown as  A-weighted Fo   Fc density contoured at 3 , almost superimposes with the
phosphate group of 2PG in T. brucei TIM, but extends in a different direction. (b) A stereo ﬁgure of the 2PG-binding environment in T. brucei TIM (PDB entry 4tim) shown
in the same orientation as in (a). 2PG is bound to the protein by a tight hydrogen-bond network. Residues to the right of the ligand are part of the closed active-site loop,
which is in the closed conformation. (c) A stereo ﬁgure of the ligand-binding environment in P. falciparum TIM (PDB entry 1o5x) shown in the same orientation as in (b).
The 2PG ligand is cleaved, possibly as a consequence of radiation damage, to 2-oxoglycerate (3PY) and metaphosphate (PO3). The active-site loop is in the open
conformation. (d) A stereo ﬁgure of the environment of the unidentiﬁed electron density in CrpaA.01119.a.A1 together with the  A-weighted OMIT 2Fo   Fc electron
density at 1  in blue and the  AOMIT Fo   Fc electron density at  3  in green/red. One protein molecule is shown with green C atoms and the crystallographic symmetry
mate is shown with purple C atoms. The unidentiﬁed electron-density blob is in proximity to the phosphate group of 2PG in T. brucei TIM; however, the glycerate group
of 2PG does not match the density. While the hydrogen-bonding partners of 2PG to the left in (b) are conserved compared with CrpaA.01119.a.A1/TIM, the different
conformations of the active-site loop render the binding environment to the right signiﬁcantly different. The unidentiﬁed electron-density blob also superimposes with the
metaphosphate in P. falciparum TIM. The right part of the extra electron density has a somewhat tetrahedral shape. However, a tentatively modelled sulfate ion (ball-and-
stick model) together with a water molecule make only very few interactions with the protein. Reﬁnement indicates that sulfate would only be at low occupancy.not contain phosphate, it did contain the isosteric sulfate ion at a
concentration of 200 mM.I nF i g .3 ( d), we have tentatively modelled a
sulfate ion and an additional water molecule into the unidentiﬁed
density. The somewhat tetrahedral shape of the right part of the
density would support this. The sulfate group would make one direct
interaction with protein (Gly235 N) and several interactions with
water molecules. However, reﬁnement indicates that the occupancy
of this sulfate would be low.
As the identity of the ligand could not be fully established, we
deposited the structure with UNK atoms in the active site. Further
crystallization experiments may identify the ligand and might estab-
lish the relationship between the conformation of the active-site loop
and ligand binding in CrpaA.01119.a.A1/TIM.
4. Conclusions
This paper describes the puriﬁcation, crystallization and structure
solutionofC.parvumtriosephosphate isomerase(CrpaA.01119.a.A1/
TIM). The presented 1.55 A ˚ resolution structure shows the typical
TIM fold and contains a dimer, which is consistent with previously
observed structures. The active-site loop is in the open conformation
which is typical for apo structures. An unidentiﬁed blob of electron
density occupies the location of phosphate moieties of ligands in
other TIM structures. However, phosphate or sulfate from the
crystallization buffer can only partially explain the extra density.
Additional studies would need to be performed in order to identify
this ligand. Furthermore, ligand-binding studies could establish the
relation between compound binding and the conformation of the
active-site loop.
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